Considering the key role of the circCUL2-induced cascade in the activation of the NF-κB/IL6 signaling pathway, targeting circCUL2 could potentially convert iCAFs into a more myofibroblastic state that has been previously suggested to inhibit tumor progression. The gene discussed is NFKB1; the disease is neoplasm.